Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.
Vosslamber S, Raterman HG, van der Pouw Kraan TC, Schreurs MW, von Blomberg BM, Nurmohamed MT, Lems WF, Dijkmans BA, Voskuyl AE, Verweij CL. Vosslamber S, et al. Among authors: von blomberg bm. Ann Rheum Dis. 2011 Jun;70(6):1153-9. doi: 10.1136/ard.2010.147199. Epub 2011 Mar 27. Ann Rheum Dis. 2011. PMID: 21444302 Clinical Trial.
B cell signature contributes to the prediction of RA development in patients with arthralgia.
Lübbers J, Vosslamber S, van de Stadt LA, van Beers-Tas M, Wesseling JG, von Blomberg BM, Witte BI, Bontkes HJ, van Schaardenburg D, Verweij CL. Lübbers J, et al. Among authors: von blomberg bm. Ann Rheum Dis. 2015 Sep;74(9):1786-8. doi: 10.1136/annrheumdis-2015-207324. Epub 2015 May 27. Ann Rheum Dis. 2015. PMID: 26019192 No abstract available.
Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M, Al-Toma A, Schreurs MW, Mulder CJ. Verbeek WH, et al. Among authors: von blomberg bm. Clin Immunol. 2008 Jan;126(1):48-56. doi: 10.1016/j.clim.2007.09.002. Epub 2007 Nov 26. Clin Immunol. 2008. PMID: 18024205
Novel approaches in the management of refractory celiac disease.
Verbeek WH, Schreurs MW, Visser OJ, von Blomberg BM, Al-Toma A, Mulder CJ. Verbeek WH, et al. Among authors: von blomberg bm. Expert Rev Clin Immunol. 2008 Mar;4(2):205-19. doi: 10.1586/1744666X.4.2.205. Expert Rev Clin Immunol. 2008. PMID: 20477051
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.
Tack GJ, van de Water JM, Bruins MJ, Kooy-Winkelaar EM, van Bergen J, Bonnet P, Vreugdenhil AC, Korponay-Szabo I, Edens L, von Blomberg BM, Schreurs MW, Mulder CJ, Koning F. Tack GJ, et al. Among authors: von blomberg bm. World J Gastroenterol. 2013 Sep 21;19(35):5837-47. doi: 10.3748/wjg.v19.i35.5837. World J Gastroenterol. 2013. PMID: 24124328 Free PMC article. Clinical Trial.
Origin and immunophenotype of aberrant IEL in RCDII patients.
Tack GJ, van Wanrooij RL, Langerak AW, Tjon JM, von Blomberg BM, Heideman DA, van Bergen J, Koning F, Bouma G, Mulder CJ, Schreurs MW. Tack GJ, et al. Among authors: von blomberg bm. Mol Immunol. 2012 Apr;50(4):262-70. doi: 10.1016/j.molimm.2012.01.014. Epub 2012 Feb 23. Mol Immunol. 2012. PMID: 22364936
147 results